Green Stephen
Department of Psychiatry, Georgetown University School of Medicine, Washington, DC, USA.
Australas Psychiatry. 2008 Jun;16(3):158-65. doi: 10.1080/10398560701842595.
Relationships between the pharmaceutical industry and the medical profession enhance the potential for physicians to become involved in conflicts of interest. Whether or not these rise to a level that violates standards of medical ethics depends on the degree to which they detract from the quality of health care and its cost, the objectivity of research, and the profession's integrity. This paper explores those issues from two perspectives--the micro-level of the medical profession and the macro-level of society.
Practices and policies that affect varied aspects of the interaction between the pharmaceutical industry and the medical profession--such as education, research and marketing--are discussed. The reader is asked to reflect on the ethics of issues raised; the author offers suggestions for mitigating conflicts of interest and, in turn, the potential for unethical medical care.
制药行业与医疗行业之间的关系增加了医生陷入利益冲突的可能性。这些冲突是否上升到违反医学伦理标准的程度，取决于它们在多大程度上损害了医疗保健的质量及其成本、研究的客观性以及行业的诚信度。本文从医疗行业的微观层面和社会的宏观层面这两个角度探讨这些问题。
讨论了影响制药行业与医疗行业之间互动的各个方面的实践和政策，如教育、研究和营销。要求读者思考所提出问题的伦理问题；作者提出了减轻利益冲突以及相应地减少不道德医疗行为可能性的建议。
